Nurix Therapeutics, Inc. (NRIX)
Market Open
26 Oct, 06:08 PM
NASDAQ (NMS) NASDAQ (NMS) Primary $
25. 52
+0.18
+0.7301%
$
2.53B Market Cap
- P/E Ratio
- Div Yield
164,177 Volume
-2.91 Eps
$ 25.34
Previous Close 
Want to track NRIX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Nurix Therapeutics, Inc. (NRIX) Statistics
Valuation metrics
Market Cap 2.53B
Enterprise value 2.11B
Trailing P/E (ttm) 10.1
Forward P/E -
PEG ratio 0.08
Price/Sales (ttm) 3.94
Price/Book (mrq) 2.92
Enterprise Value/Revenue 3.01
Enterprise Value/EBITDA 6.55
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 3.21M
Average volume (90 days) 1.63M
Price summary
52-Week low 11.19
52-Week high 28.23
Beta -
50-Day moving average 24.37
200-Day moving average 21.5
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.42%
Operating margin 0.41%
Operational effectiveness
Return on assets 0.25%
Return on equity 0.49%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 6.29
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 2.64
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 9.4
Total debt (mrq) -
Total Debt/Equity (mrq) 0.07
Current ratio (mrq) 8.44%
Book value per share (mrq) 8.68
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
